Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 23.45
+0.05 (0.21%)
Oct 30, 2026, 5:35 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.72 billion as of October 30, 2026. It is the 6,668th most valuable company in the world and the 33rd biggest in Belgium. Its market cap has increased by 14.06% in one year.
Market Cap
1.72B
Enterprise Value
2.23B
Revenue
1.03B
Global Rank
Country Rank
#33 Belgium
PE Ratio
18.76
ChartMarket Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.72B, an increase of 450.98%. That is a compound annual growth rate of 9.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.72B | 10.25% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.23B |
| argenx SE | 48.95B |
| Financière de Tubize | 9.79B |
| Ion Beam Applications | 475.30M |
| Onward Medical | 157.14M |
| Hyloris Pharmaceuticals | 102.20M |
| Nyxoah | 83.56M |
| Sequana Medical NV | 43.56M |